They have improved insulin resistance, blood pressure, lipids, inflammatory markers, knee osteoarthritis, and have gained indications for glycemic control, fatty liver disease, cardiovascular risk, chronic kidney disease in those living with type 2 diabetes
While peptide-based GLP-1R agonists such as semaglutide have transformed the treatment landscape, dual incretin receptor engagement further enhances metabolic outcomes
The risks of metabolic and bariatric surgery are so low now that the death rate and complication rates are lower than laparoscopic gallbladder removal, which a lot of people have had done, says Dr
It helps the liver process waste and supports the immune system by ensuring that white blood cells have the energy and structural integrity they need to function
Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial
This is absolutely fantastic, says Nancy Nielsen, MD, PhD, a senior associate dean for health policy at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in New York
